These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23014518)

  • 1. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.
    Singh R; Marshall N; Smith CJ; Reynolds CJ; Breen RA; Bhagani S; Cropley I; Hopkins S; Swaden L; Johnson MA; Lipman MC
    AIDS; 2013 Jan; 27(3):481-4. PubMed ID: 23014518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.
    Burman W; Benator D; Vernon A; Khan A; Jones B; Silva C; Lahart C; Weis S; King B; Mangura B; Weiner M; El-Sadr W;
    Am J Respir Crit Care Med; 2006 Feb; 173(3):350-6. PubMed ID: 16109981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
    Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
    Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.
    Nettles RE; Mazo D; Alwood K; Gachuhi R; Maltas G; Wendel K; Cronin W; Hooper N; Bishai W; Sterling TR
    Clin Infect Dis; 2004 Mar; 38(5):731-6. PubMed ID: 14986259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
    Loeliger A; Suthar AB; Ripin D; Glaziou P; O'Brien M; Renaud-Thery F; Crowley S; Williams B; Ridzon R; Granich R; Gilks C
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):6-15. PubMed ID: 21819645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifamycin-resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: a report of 3 relapses with acquired rifampin resistance following alternate-day rifabutin and boosted protease inhibitor therapy.
    Jenny-Avital ER; Joseph K
    Clin Infect Dis; 2009 May; 48(10):1471-4. PubMed ID: 19368504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
    Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
    J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
    Ifebunandu NA; Ukwaja KN; Obi SN
    Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis.
    Schwander S; Rüsch-Gerdes S; Mateega A; Lutalo T; Tugume S; Kityo C; Rubaramira R; Mugyenyi P; Okwera A; Mugerwa R
    Tuber Lung Dis; 1995 Jun; 76(3):210-8. PubMed ID: 7548903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis and HIV co-infection: a practical therapeutic approach.
    Breen RA; Swaden L; Ballinger J; Lipman MC
    Drugs; 2006; 66(18):2299-308. PubMed ID: 17181373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TB drugs interact adversely with protease inhibitors.
    AIDS Alert; 1996 Oct; 11(10):117-8. PubMed ID: 11363854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
    Burman W; Weis S; Vernon A; Khan A; Benator D; Jones B; Silva C; King B; LaHart C; Mangura B; Weiner M; El-Sadr W
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1282-9. PubMed ID: 18229435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The tolerability and therapeutic efficacy of rifabutin in the treatment of pulmonary tuberculosis].
    Parola D; Dell'Orso D; Giovagnoli S; Bianconi S; Terzano C
    Recenti Prog Med; 1999 May; 90(5):254-7. PubMed ID: 10380552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.
    TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607
    [No Abstract]   [Full Text] [Related]  

  • 17. Updated guidelines for the use of rifamycins in HIV/TB-coinfected patients.
    del Rio C
    AIDS Clin Care; 2004 Oct; 16(10):85. PubMed ID: 15526395
    [No Abstract]   [Full Text] [Related]  

  • 18. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global access of rifabutin for the treatment of tuberculosis - why should we prioritize this?
    Rockwood N; Cerrone M; Barber M; Hill AM; Pozniak AL
    J Int AIDS Soc; 2019 Jul; 22(7):e25333. PubMed ID: 31318176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial extensively drug-resistant tuberculosis in an HIV-infected child: a case report and review of literature.
    Uppuluri R; Shah I
    J Int Assoc Provid AIDS Care; 2014; 13(2):117-9. PubMed ID: 24401768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.